Description
Gemcitabine Injection 1000 mg
Aark Pharmaceuticals is a leading supplier and exporter of Gemcitabine Injection 1000 mg in various packaging. Gemcitabine is indicated in combination with cisplatin for the treatment of locally advanced or metastatic bladder cancer. Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. Gemcitabine, in combination with cisplatin, is indicated for first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). Gemcitabine monotherapy may be considered for elderly patients or patients with performance status 2.